Pharmafile Logo
Pharmafocus logo
Advanced Search
forxiga

AstraZeneca scores positive real-world Forxiga data

September 16, 2015
Research and Development AstraZeneca, EASD, European Association for the Study of Diabetes, Forxiga, dapagliflozin, exenatide, real world data, real world evidence

The real-world study of AstraZeneca’s diabetes drug Forxiga has found its use in UK patients primary care patients supports the …

News
GSK Worthing

GSK recalls 427,000 antibiotics after contamination scare

September 15, 2015
Manufacturing and Production Bactroban, FDA, GSK, manufacturing, product recalls, production, recalls

GlaxoSmithKline has had to recall more than 427,000 tubes of creams and ointments due to potential penicillin cross-contamination and the …

News

Sanofi to significantly expand UK inhaler plant

September 15, 2015
Manufacturing and Production Cheshire, Sanofi, manufacturing, production

Sanofi is gearing up for significant expansion of its inhaler production complex in Cheshire, England. The French pharma giant has …

News
astrazeneca image

AstraZeneca purchases former Amgen US facility

September 15, 2015
Manufacturing and Production Amgen, AstraZeneca, US, biologics, manufacturing, production

AstraZeneca has bolstered its US presence with the purchase of a high-tech biologics manufacturing facility from pharma rival Amgen. The …

News
mike_maclean

PureTech appoints Michael MacLean as chief financial officer

September 14, 2015
Medical Communications, Research and Development, Sales and Marketing Michael MacLean, PureTech Health

PureTech Health has appointed Michael MacLean to the management team, as chief financial officer and executive vice president. Michael MacLean …

Appointment

Counting the true cost of the Cancer Drugs Fund cuts

September 14, 2015
Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology

Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …

Feature
fda_building

FDA strengthens safety warning for J&J’s diabetes drug Invokana

September 14, 2015
Sales and Marketing FDA, Food and Drugs Administration, Invokamet, J&J, JJ, Johnson & Johnson, diabetes, invokana, safety warning, type 2 diabetes

Johnson & Johnson has suffered a blow after the FDA strengthened its safety warning for the company’s type 2 diabetes …

News
janssen_stairs

Janssen submits EMA application for myeloma drug

September 14, 2015
Sales and Marketing Janssen, daratumumab, multiple myeloma

Janssen has submitted a new marketing authorisation application for European approval of daratumumab for the treatment of patients with relapsed …

News
ofev1

Boehringer earns NICE nod for IPF drug Ofev

September 14, 2015
Sales and Marketing Boehringer Ingelheim, IPF, NICE, idiopathic pulmonary fibrosis

NICE has recommended Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis after the German firm agreed to a …

News
big pharma game

The making of a modern pharma blockbuster

September 11, 2015
Medical Communications Big Pharma, Twice Circled, computer game

The pharma industry divides opinions on its morality, but what has always stood out is the fact that in this …

Feature
Proteus system

US FDA accepts first digital medicine application

September 11, 2015
Medical Communications FDA, NDA, Otsuka, digital, digital medicine, proteus

The FDA has accepted the first New Drug Application for a digital medicine: Otsuka and Proteus Digital Health’s collaboration of …

News
Naomi Landman

Supply chain leaders call for forward pharma thinking

September 11, 2015
Manufacturing and Production, Medical Communications fly pharma, fly pharma conference, logistics, supply chain

Logistics companies must improve their understanding of the pharma industry to better serve their customers, according to a supply chain …

News
david_thompson

Envision Pharma acquires two medical education specialists in takeover deal

September 11, 2015
Medical Communications

Two principals from Alligent Biopharm Consulting have joined the UK communications group Envision Pharma following an acquisition deal.Alligent’s two principals, …

Appointment
lab sign

Medimmune and Cancer Research UK launch new drug discovery lab

September 11, 2015
Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman

MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …

News
body scan

Pfizer in metabolic disease push

September 11, 2015
Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions.  …

News
zs-pharma-logo_cmyk

Actelion confirms takeover talks with ZS Pharma

September 11, 2015
Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …

News
lyrica

High Court rules against Pfizer in Lyrica patent case

September 10, 2015
Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …

News
john_jeans

EM Imaging appoints new chairman

September 10, 2015
Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology

The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …

Appointment
heart_rate_monitor_app

Featured market report: Healthcare mobility solutions market by products and services, global forecast to 2020

September 10, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing apps, healthcare mobility, market report, mobile healthcare, smartphones

The global healthcare mobility solutions market is set to grow by as much as 30% to 2020, as the healthcare …

Feature
lung cancer x ray

Lung cancer market to hit $10.9bn by 2021

September 10, 2015
Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer

The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026